Header Logo

Connection

ELIAS JOSEPH JABBOUR to Dizziness

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Dizziness.
ELIAS JOSEPH JABBOUR
Connection Strength
0.031
Dizziness
  1. Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome. Leuk Lymphoma. 2015 Feb; 56(2):395-400.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.